Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Review Article

BTDMJB. 2007; 3(4): 125-129

Iron chelation therapy in thalassemia major

Şirin Güven, Makbule Erdoğan.

Reduced or absent production of ß-globin chains causes an excess of instable ß chains which are responsible for decreased erythrocyte survival, severe anemia and related complications. Anemia, iron overload and iron toxicity are the main factors in homozygous ß-thalassemia. Transfusion is very important for normal development but causes iron overload. Iron overload in thalassemic patients is variable depending on degree of anemia, degree of erythrocyte destruction, transfusional load and chelating therapy. Inappropriate iron
chelation leads to progressive organ damage; the organs which are more frequently affected are the heart, liver and endocrine glands.

Key words: Thalassemia, iron chelation therapy

Article Language: Turkish English

Full-text options

Full-text Article

Journal of Contemporary Medical Education


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.